Comparison of clinical and laboratory features and treatment options of 237 Comparison of clinical and laboratory features and treatment options of 237 symptomatic and asymptomatic children infected with SARS-CoV-2 in the early phase of the COVID-19 pandemic in Turkey.
Identifieur interne : 000754 ( Main/Curation ); précédent : 000753; suivant : 000755Comparison of clinical and laboratory features and treatment options of 237 Comparison of clinical and laboratory features and treatment options of 237 symptomatic and asymptomatic children infected with SARS-CoV-2 in the early phase of the COVID-19 pandemic in Turkey.
Auteurs : Ahmet Soysal [Turquie] ; Erdem Gönüllü [Turquie] ; Hüseyin Arslan [Turquie] ; Bü Ra Sultan Kibar [Turquie] ; Serdar Pop [Turquie] ; Gözde Nur Yurtta [Turquie] ; Hacer Demirbacak [Turquie] ; Füsun Ünal [Turquie] ; Sedat Öktem [Turquie] ; Serkan At C [Turquie] ; Arife Derda Yücel En [Turquie] ; Nalan Karabay R [Turquie] ; Metin Karaböcüo Lu [Turquie]Source :
- Japanese journal of infectious diseases [ 1884-2836 ] ; 2020.
Abstract
Since the first report of COVID-19 in December 2019, little is known about therapeutic usage of hydroxychloroquine in pediatric patients with COVID-19. We retrospectively retrieved data for SARS-CoV-2 PCR positive pediatric patients from 20 hospitals in 8 different cities in Turkey. We obtained patients' epidemiological, clinical, laboratory features and drugs used for treatment of COVID-19. 237 nasopharyngeal swab SARS-CoV-2 PCR positive children were included into the study from March 26 to June 20, 2020. The mean age of asymptomatic children (118±62 months) was found to be higher than that of symptomatic children (89±69 months). Symptomatic children had a significantly lower mean lymphocyte count and higher mean CRP, D-dimer value, procalcitonin and LDH than asymptomatic children in univariate analysis. Out of 156 children, 78 (50%) children received Hydroxychloroquine-containing regimen, 15 of them were treated with hydroxychloroquine + azithromycin + oseltamivir, 44 were treated with hydroxychloroquine + azithromycin and 21 were only treated with hydroxychloroquine. Among the 156 patients who received medical treatment, 90 (58%) patients had pre and/or post-treatment ECG performed upon them. However, none of them either reported ECG abnormalities or a need for discontinuation of hydroxychloroquine because of adverse drug reaction.
DOI: 10.7883/yoken.JJID.2020.781
PubMed: 33250495
Links toward previous steps (curation, corpus...)
- to stream Main, to step Corpus: Pour aller vers cette notice dans l'étape Curation :000754
Links to Exploration step
pubmed:33250495Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Comparison of clinical and laboratory features and treatment options of 237 Comparison of clinical and laboratory features and treatment options of 237 symptomatic and asymptomatic children infected with SARS-CoV-2 in the early phase of the COVID-19 pandemic in Turkey.</title>
<author><name sortKey="Soysal, Ahmet" sort="Soysal, Ahmet" uniqKey="Soysal A" first="Ahmet" last="Soysal">Ahmet Soysal</name>
<affiliation wicri:level="1"><nlm:affiliation>Division of Pediatric Infectious Diseases, Memorial Ataşehir Hospital, Turkey.</nlm:affiliation>
<country xml:lang="fr">Turquie</country>
<wicri:regionArea>Division of Pediatric Infectious Diseases, Memorial Ataşehir Hospital</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Gonullu, Erdem" sort="Gonullu, Erdem" uniqKey="Gonullu E" first="Erdem" last="Gönüllü">Erdem Gönüllü</name>
<affiliation wicri:level="1"><nlm:affiliation>Division of Pediatric Infectious Diseases, Memorial Ataşehir Hospital, Turkey.</nlm:affiliation>
<country xml:lang="fr">Turquie</country>
<wicri:regionArea>Division of Pediatric Infectious Diseases, Memorial Ataşehir Hospital</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Arslan, Huseyin" sort="Arslan, Huseyin" uniqKey="Arslan H" first="Hüseyin" last="Arslan">Hüseyin Arslan</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Pediatrics, Medipol University, Turkey.</nlm:affiliation>
<country xml:lang="fr">Turquie</country>
<wicri:regionArea>Department of Pediatrics, Medipol University</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Kibar, Bu Ra Sultan" sort="Kibar, Bu Ra Sultan" uniqKey="Kibar B" first="Bü Ra Sultan" last="Kibar">Bü Ra Sultan Kibar</name>
<affiliation wicri:level="1"><nlm:affiliation>Yalova State Hospital, Turkey.</nlm:affiliation>
<country xml:lang="fr">Turquie</country>
<wicri:regionArea>Yalova State Hospital</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Pop, Serdar" sort="Pop, Serdar" uniqKey="Pop S" first="Serdar" last="Pop">Serdar Pop</name>
<affiliation wicri:level="1"><nlm:affiliation>Erbaa State Hospital, Turkey.</nlm:affiliation>
<country xml:lang="fr">Turquie</country>
<wicri:regionArea>Erbaa State Hospital</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Yurtta, Gozde Nur" sort="Yurtta, Gozde Nur" uniqKey="Yurtta G" first="Gözde Nur" last="Yurtta">Gözde Nur Yurtta</name>
<affiliation wicri:level="1"><nlm:affiliation>Tokat State Hospital, Turkey.</nlm:affiliation>
<country xml:lang="fr">Turquie</country>
<wicri:regionArea>Tokat State Hospital</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Demirbacak, Hacer" sort="Demirbacak, Hacer" uniqKey="Demirbacak H" first="Hacer" last="Demirbacak">Hacer Demirbacak</name>
<affiliation wicri:level="1"><nlm:affiliation>Yalova State Hospital, Turkey.</nlm:affiliation>
<country xml:lang="fr">Turquie</country>
<wicri:regionArea>Yalova State Hospital</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Unal, Fusun" sort="Unal, Fusun" uniqKey="Unal F" first="Füsun" last="Ünal">Füsun Ünal</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Pediatrics, Medipol University, Turkey.</nlm:affiliation>
<country xml:lang="fr">Turquie</country>
<wicri:regionArea>Department of Pediatrics, Medipol University</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Oktem, Sedat" sort="Oktem, Sedat" uniqKey="Oktem S" first="Sedat" last="Öktem">Sedat Öktem</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Pediatrics, Medipol University, Turkey.</nlm:affiliation>
<country xml:lang="fr">Turquie</country>
<wicri:regionArea>Department of Pediatrics, Medipol University</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="At C, Serkan" sort="At C, Serkan" uniqKey="At C S" first="Serkan" last="At C">Serkan At C</name>
<affiliation wicri:level="1"><nlm:affiliation>Division of Pediatric Infectious Diseases, Okan University Hospital, Turkey.</nlm:affiliation>
<country xml:lang="fr">Turquie</country>
<wicri:regionArea>Division of Pediatric Infectious Diseases, Okan University Hospital</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey=" En, Arife Derda Yucel" sort=" En, Arife Derda Yucel" uniqKey=" En A" first="Arife Derda Yücel" last=" En">Arife Derda Yücel En</name>
<affiliation wicri:level="1"><nlm:affiliation>Yalova State Hospital, Turkey.</nlm:affiliation>
<country xml:lang="fr">Turquie</country>
<wicri:regionArea>Yalova State Hospital</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Karabay R, Nalan" sort="Karabay R, Nalan" uniqKey="Karabay R N" first="Nalan" last="Karabay R">Nalan Karabay R</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Pediatrics, Medipol University, Turkey.</nlm:affiliation>
<country xml:lang="fr">Turquie</country>
<wicri:regionArea>Department of Pediatrics, Medipol University</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Karabocuo Lu, Metin" sort="Karabocuo Lu, Metin" uniqKey="Karabocuo Lu M" first="Metin" last="Karaböcüo Lu">Metin Karaböcüo Lu</name>
<affiliation wicri:level="1"><nlm:affiliation>Division of Pediatric Infectious Diseases, Memorial Ataşehir Hospital, Turkey.</nlm:affiliation>
<country xml:lang="fr">Turquie</country>
<wicri:regionArea>Division of Pediatric Infectious Diseases, Memorial Ataşehir Hospital</wicri:regionArea>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2020">2020</date>
<idno type="RBID">pubmed:33250495</idno>
<idno type="pmid">33250495</idno>
<idno type="doi">10.7883/yoken.JJID.2020.781</idno>
<idno type="wicri:Area/Main/Corpus">000754</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">000754</idno>
<idno type="wicri:Area/Main/Curation">000754</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">000754</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Comparison of clinical and laboratory features and treatment options of 237 Comparison of clinical and laboratory features and treatment options of 237 symptomatic and asymptomatic children infected with SARS-CoV-2 in the early phase of the COVID-19 pandemic in Turkey.</title>
<author><name sortKey="Soysal, Ahmet" sort="Soysal, Ahmet" uniqKey="Soysal A" first="Ahmet" last="Soysal">Ahmet Soysal</name>
<affiliation wicri:level="1"><nlm:affiliation>Division of Pediatric Infectious Diseases, Memorial Ataşehir Hospital, Turkey.</nlm:affiliation>
<country xml:lang="fr">Turquie</country>
<wicri:regionArea>Division of Pediatric Infectious Diseases, Memorial Ataşehir Hospital</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Gonullu, Erdem" sort="Gonullu, Erdem" uniqKey="Gonullu E" first="Erdem" last="Gönüllü">Erdem Gönüllü</name>
<affiliation wicri:level="1"><nlm:affiliation>Division of Pediatric Infectious Diseases, Memorial Ataşehir Hospital, Turkey.</nlm:affiliation>
<country xml:lang="fr">Turquie</country>
<wicri:regionArea>Division of Pediatric Infectious Diseases, Memorial Ataşehir Hospital</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Arslan, Huseyin" sort="Arslan, Huseyin" uniqKey="Arslan H" first="Hüseyin" last="Arslan">Hüseyin Arslan</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Pediatrics, Medipol University, Turkey.</nlm:affiliation>
<country xml:lang="fr">Turquie</country>
<wicri:regionArea>Department of Pediatrics, Medipol University</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Kibar, Bu Ra Sultan" sort="Kibar, Bu Ra Sultan" uniqKey="Kibar B" first="Bü Ra Sultan" last="Kibar">Bü Ra Sultan Kibar</name>
<affiliation wicri:level="1"><nlm:affiliation>Yalova State Hospital, Turkey.</nlm:affiliation>
<country xml:lang="fr">Turquie</country>
<wicri:regionArea>Yalova State Hospital</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Pop, Serdar" sort="Pop, Serdar" uniqKey="Pop S" first="Serdar" last="Pop">Serdar Pop</name>
<affiliation wicri:level="1"><nlm:affiliation>Erbaa State Hospital, Turkey.</nlm:affiliation>
<country xml:lang="fr">Turquie</country>
<wicri:regionArea>Erbaa State Hospital</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Yurtta, Gozde Nur" sort="Yurtta, Gozde Nur" uniqKey="Yurtta G" first="Gözde Nur" last="Yurtta">Gözde Nur Yurtta</name>
<affiliation wicri:level="1"><nlm:affiliation>Tokat State Hospital, Turkey.</nlm:affiliation>
<country xml:lang="fr">Turquie</country>
<wicri:regionArea>Tokat State Hospital</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Demirbacak, Hacer" sort="Demirbacak, Hacer" uniqKey="Demirbacak H" first="Hacer" last="Demirbacak">Hacer Demirbacak</name>
<affiliation wicri:level="1"><nlm:affiliation>Yalova State Hospital, Turkey.</nlm:affiliation>
<country xml:lang="fr">Turquie</country>
<wicri:regionArea>Yalova State Hospital</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Unal, Fusun" sort="Unal, Fusun" uniqKey="Unal F" first="Füsun" last="Ünal">Füsun Ünal</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Pediatrics, Medipol University, Turkey.</nlm:affiliation>
<country xml:lang="fr">Turquie</country>
<wicri:regionArea>Department of Pediatrics, Medipol University</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Oktem, Sedat" sort="Oktem, Sedat" uniqKey="Oktem S" first="Sedat" last="Öktem">Sedat Öktem</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Pediatrics, Medipol University, Turkey.</nlm:affiliation>
<country xml:lang="fr">Turquie</country>
<wicri:regionArea>Department of Pediatrics, Medipol University</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="At C, Serkan" sort="At C, Serkan" uniqKey="At C S" first="Serkan" last="At C">Serkan At C</name>
<affiliation wicri:level="1"><nlm:affiliation>Division of Pediatric Infectious Diseases, Okan University Hospital, Turkey.</nlm:affiliation>
<country xml:lang="fr">Turquie</country>
<wicri:regionArea>Division of Pediatric Infectious Diseases, Okan University Hospital</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey=" En, Arife Derda Yucel" sort=" En, Arife Derda Yucel" uniqKey=" En A" first="Arife Derda Yücel" last=" En">Arife Derda Yücel En</name>
<affiliation wicri:level="1"><nlm:affiliation>Yalova State Hospital, Turkey.</nlm:affiliation>
<country xml:lang="fr">Turquie</country>
<wicri:regionArea>Yalova State Hospital</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Karabay R, Nalan" sort="Karabay R, Nalan" uniqKey="Karabay R N" first="Nalan" last="Karabay R">Nalan Karabay R</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Pediatrics, Medipol University, Turkey.</nlm:affiliation>
<country xml:lang="fr">Turquie</country>
<wicri:regionArea>Department of Pediatrics, Medipol University</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Karabocuo Lu, Metin" sort="Karabocuo Lu, Metin" uniqKey="Karabocuo Lu M" first="Metin" last="Karaböcüo Lu">Metin Karaböcüo Lu</name>
<affiliation wicri:level="1"><nlm:affiliation>Division of Pediatric Infectious Diseases, Memorial Ataşehir Hospital, Turkey.</nlm:affiliation>
<country xml:lang="fr">Turquie</country>
<wicri:regionArea>Division of Pediatric Infectious Diseases, Memorial Ataşehir Hospital</wicri:regionArea>
</affiliation>
</author>
</analytic>
<series><title level="j">Japanese journal of infectious diseases</title>
<idno type="eISSN">1884-2836</idno>
<imprint><date when="2020" type="published">2020</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass></textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Since the first report of COVID-19 in December 2019, little is known about therapeutic usage of hydroxychloroquine in pediatric patients with COVID-19. We retrospectively retrieved data for SARS-CoV-2 PCR positive pediatric patients from 20 hospitals in 8 different cities in Turkey. We obtained patients' epidemiological, clinical, laboratory features and drugs used for treatment of COVID-19. 237 nasopharyngeal swab SARS-CoV-2 PCR positive children were included into the study from March 26 to June 20, 2020. The mean age of asymptomatic children (118±62 months) was found to be higher than that of symptomatic children (89±69 months). Symptomatic children had a significantly lower mean lymphocyte count and higher mean CRP, D-dimer value, procalcitonin and LDH than asymptomatic children in univariate analysis. Out of 156 children, 78 (50%) children received Hydroxychloroquine-containing regimen, 15 of them were treated with hydroxychloroquine + azithromycin + oseltamivir, 44 were treated with hydroxychloroquine + azithromycin and 21 were only treated with hydroxychloroquine. Among the 156 patients who received medical treatment, 90 (58%) patients had pre and/or post-treatment ECG performed upon them. However, none of them either reported ECG abnormalities or a need for discontinuation of hydroxychloroquine because of adverse drug reaction.</div>
</front>
</TEI>
<pubmed><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">33250495</PMID>
<DateRevised><Year>2020</Year>
<Month>11</Month>
<Day>30</Day>
</DateRevised>
<Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1884-2836</ISSN>
<JournalIssue CitedMedium="Internet"><PubDate><Year>2020</Year>
<Month>Nov</Month>
<Day>30</Day>
</PubDate>
</JournalIssue>
<Title>Japanese journal of infectious diseases</Title>
<ISOAbbreviation>Jpn J Infect Dis</ISOAbbreviation>
</Journal>
<ArticleTitle>Comparison of clinical and laboratory features and treatment options of 237 Comparison of clinical and laboratory features and treatment options of 237 symptomatic and asymptomatic children infected with SARS-CoV-2 in the early phase of the COVID-19 pandemic in Turkey.</ArticleTitle>
<ELocationID EIdType="doi" ValidYN="Y">10.7883/yoken.JJID.2020.781</ELocationID>
<Abstract><AbstractText>Since the first report of COVID-19 in December 2019, little is known about therapeutic usage of hydroxychloroquine in pediatric patients with COVID-19. We retrospectively retrieved data for SARS-CoV-2 PCR positive pediatric patients from 20 hospitals in 8 different cities in Turkey. We obtained patients' epidemiological, clinical, laboratory features and drugs used for treatment of COVID-19. 237 nasopharyngeal swab SARS-CoV-2 PCR positive children were included into the study from March 26 to June 20, 2020. The mean age of asymptomatic children (118±62 months) was found to be higher than that of symptomatic children (89±69 months). Symptomatic children had a significantly lower mean lymphocyte count and higher mean CRP, D-dimer value, procalcitonin and LDH than asymptomatic children in univariate analysis. Out of 156 children, 78 (50%) children received Hydroxychloroquine-containing regimen, 15 of them were treated with hydroxychloroquine + azithromycin + oseltamivir, 44 were treated with hydroxychloroquine + azithromycin and 21 were only treated with hydroxychloroquine. Among the 156 patients who received medical treatment, 90 (58%) patients had pre and/or post-treatment ECG performed upon them. However, none of them either reported ECG abnormalities or a need for discontinuation of hydroxychloroquine because of adverse drug reaction.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Soysal</LastName>
<ForeName>Ahmet</ForeName>
<Initials>A</Initials>
<AffiliationInfo><Affiliation>Division of Pediatric Infectious Diseases, Memorial Ataşehir Hospital, Turkey.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Gönüllü</LastName>
<ForeName>Erdem</ForeName>
<Initials>E</Initials>
<AffiliationInfo><Affiliation>Division of Pediatric Infectious Diseases, Memorial Ataşehir Hospital, Turkey.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Arslan</LastName>
<ForeName>Hüseyin</ForeName>
<Initials>H</Initials>
<AffiliationInfo><Affiliation>Department of Pediatrics, Medipol University, Turkey.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Kibar</LastName>
<ForeName>Büşra Sultan</ForeName>
<Initials>BS</Initials>
<AffiliationInfo><Affiliation>Yalova State Hospital, Turkey.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Pop</LastName>
<ForeName>Serdar</ForeName>
<Initials>S</Initials>
<AffiliationInfo><Affiliation>Erbaa State Hospital, Turkey.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Yurttaş</LastName>
<ForeName>Gözde Nur</ForeName>
<Initials>GN</Initials>
<AffiliationInfo><Affiliation>Tokat State Hospital, Turkey.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Demirbacak</LastName>
<ForeName>Hacer</ForeName>
<Initials>H</Initials>
<AffiliationInfo><Affiliation>Yalova State Hospital, Turkey.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Ünal</LastName>
<ForeName>Füsun</ForeName>
<Initials>F</Initials>
<AffiliationInfo><Affiliation>Department of Pediatrics, Medipol University, Turkey.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Öktem</LastName>
<ForeName>Sedat</ForeName>
<Initials>S</Initials>
<AffiliationInfo><Affiliation>Department of Pediatrics, Medipol University, Turkey.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Atıcı</LastName>
<ForeName>Serkan</ForeName>
<Initials>S</Initials>
<AffiliationInfo><Affiliation>Division of Pediatric Infectious Diseases, Okan University Hospital, Turkey.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Şen</LastName>
<ForeName>Arife Derda Yücel</ForeName>
<Initials>ADY</Initials>
<AffiliationInfo><Affiliation>Yalova State Hospital, Turkey.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Karabayır</LastName>
<ForeName>Nalan</ForeName>
<Initials>N</Initials>
<AffiliationInfo><Affiliation>Department of Pediatrics, Medipol University, Turkey.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Karaböcüoğlu</LastName>
<ForeName>Metin</ForeName>
<Initials>M</Initials>
<AffiliationInfo><Affiliation>Division of Pediatric Infectious Diseases, Memorial Ataşehir Hospital, Turkey.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><CollectiveName>PEDCOVID19 study group.</CollectiveName>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic"><Year>2020</Year>
<Month>11</Month>
<Day>30</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo><Country>Japan</Country>
<MedlineTA>Jpn J Infect Dis</MedlineTA>
<NlmUniqueID>100893704</NlmUniqueID>
<ISSNLinking>1344-6304</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Hydroxychloroquine</Keyword>
<Keyword MajorTopicYN="N">SARS-CoV-2</Keyword>
<Keyword MajorTopicYN="N">Turkey </Keyword>
</KeywordList>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2020</Year>
<Month>11</Month>
<Day>30</Day>
<Hour>5</Hour>
<Minute>51</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed"><Year>2020</Year>
<Month>12</Month>
<Day>1</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2020</Year>
<Month>12</Month>
<Day>1</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>aheadofprint</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">33250495</ArticleId>
<ArticleId IdType="doi">10.7883/yoken.JJID.2020.781</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/CovidChloroV1/Data/Main/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000754 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Curation/biblio.hfd -nk 000754 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Sante |area= CovidChloroV1 |flux= Main |étape= Curation |type= RBID |clé= pubmed:33250495 |texte= Comparison of clinical and laboratory features and treatment options of 237 Comparison of clinical and laboratory features and treatment options of 237 symptomatic and asymptomatic children infected with SARS-CoV-2 in the early phase of the COVID-19 pandemic in Turkey. }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Curation/RBID.i -Sk "pubmed:33250495" \ | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Curation/biblio.hfd \ | NlmPubMed2Wicri -a CovidChloroV1
![]() | This area was generated with Dilib version V0.6.38. | ![]() |